Cargando…

Quantitative Appraisal of Ventricular Cerebrospinal Fluid Biomarkers in Neuropathologically Diagnosed Parkinson’s Disease Cases Lacking Alzheimer’s Disease Pathology

Identifying biomarkers that distinguish Parkinson’s disease (PD) from normal control (NC) individuals has the potential to increase diagnostic sensitivity for the detection of early-stage PD. A previous proteomic study identified potential biomarkers in postmortem ventricular cerebrospinal fluid (V-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maarouf, Chera L., Beach, Thomas G., Adler, Charles H., Malek-Ahmadi, Michael, Kokjohn, Tyler A., Dugger, Brittany N., Walker, Douglas G., Shill, Holly A., Jacobson, Sandra A., Sabbagh, Marwan N., Roher, Alex E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603385/ https://www.ncbi.nlm.nih.gov/pubmed/23533154 http://dx.doi.org/10.4137/BMI.S11422

Ejemplares similares

Morphological and Pathological Evolution of the Brain Microcirculation in Aging and Alzheimer’s Disease
por: Hunter, Jesse M., et al.
Publicado: (2012)

Molecular Differences and Similarities Between Alzheimer’s Disease and the 5XFAD Transgenic Mouse Model of Amyloidosis
por: Maarouf, Chera L, et al.
Publicado: (2013)

Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairment
por: Dugger, Brittany N., et al.
Publicado: (2015)

Biochemical Assessment of Precuneus and Posterior Cingulate Gyrus in the Context of Brain Aging and Alzheimer’s Disease
por: Maarouf, Chera L., et al.
Publicado: (2014)

Cerebral blood flow in Alzheimer’s disease
por: Roher, Alex E, et al.
Publicado: (2012)

Alzheimer's Disease and Non-Demented High Pathology Control Nonagenarians: Comparing and Contrasting the Biochemistry of Cognitively Successful Aging
por: Maarouf, Chera L., et al.
Publicado: (2011)

The influence of Apolipoprotein E genotype on regional pathology in Alzheimer’s disease
por: Sabbagh, Marwan N, et al.
Publicado: (2013)

Impaired hepatic amyloid-beta degradation in Alzheimer’s disease
por: Maarouf, Chera L., et al.
Publicado: (2018)

The biochemical aftermath of anti-amyloid immunotherapy
por: Maarouf, Chera L, et al.
Publicado: (2010)

Bapineuzumab Alters Aβ Composition: Implications for the Amyloid Cascade Hypothesis and Anti-Amyloid Immunotherapy
por: Roher, Alex E., et al.
Publicado: (2013)

Reduced clinical and postmortem measures of cardiac pathology in subjects with advanced Alzheimer's Disease
por: Beach, Thomas G, et al.
Publicado: (2011)

Advances in Deep Neuropathological Phenotyping of Alzheimer Disease: Past, Present, and Future
por: Shakir, Mustafa N, et al.
Publicado: (2022)

Differences in Cerebrospinal Fluid Biomarkers between Clinically Diagnosed Idiopathic Normal Pressure Hydrocephalus and Alzheimer’s Disease
por: Tsai, Andrew, et al.
Publicado: (2014)

Profiles of Extracellular miRNA in Cerebrospinal Fluid and Serum from Patients with Alzheimer's and Parkinson's Diseases Correlate with Disease Status and Features of Pathology
por: Burgos, Kasandra, et al.
Publicado: (2014)

Essential Tremor in the Elderly and Risk for Dementia
por: Shill, Holly A., et al.
Publicado: (2014)

Improved diagnosis of Parkinson's disease from a detailed olfactory phenotype
por: Gerkin, Richard C., et al.
Publicado: (2017)

Prevalence of Hippocampal Sclerosis in a Clinicopathologically Characterized Cohort
por: Malek-Ahmadi, Michael, et al.
Publicado: (2013)

Histopathological and molecular heterogeneity among individuals with dementia associated with Presenilin mutations
por: Maarouf, Chera L, et al.
Publicado: (2008)

SMG1 Identified as a Regulator of Parkinson’s Disease-Associated alpha-Synuclein through siRNA Screening
por: Henderson-Smith, Adrienne, et al.
Publicado: (2013)

Severe hyposmia distinguishes neuropathologically confirmed dementia with Lewy bodies from Alzheimer’s disease dementia
por: Beach, Thomas G., et al.
Publicado: (2020)

Neuropathology studies of dementia in US persons other than non-Hispanic whites
por: Nguyen, My-le, et al.
Publicado: (2022)

The neuropathological landscape of Hispanic and non-Hispanic White decedents with Alzheimer disease
por: Scalco, Rebeca, et al.
Publicado: (2023)

KIF6 719Arg Carrier Status Association with Homocysteine and C-Reactive Protein in Amnestic Mild Cognitive Impairment and Alzheimer's Disease Patients
por: Malek-Ahmadi, Michael, et al.
Publicado: (2013)

Informant-reported cognitive symptoms that predict amnestic mild cognitive impairment
por: Malek-Ahmadi, Michael, et al.
Publicado: (2012)

Platelet BACE1 levels as a possible biomarker for Alzheimer’s disease
por: Decourt, Boris, et al.
Publicado: (2013)

Sensitivity to change and prediction of global change for the Alzheimer’s Questionnaire
por: Malek-Ahmadi, Michael, et al.
Publicado: (2015)

BrainSec: Automated Brain Tissue Segmentation Pipeline for Scalable Neuropathological Analysis
por: LAI, ZHENGFENG, et al.
Publicado: (2022)

Investigational drugs for the treatment of AD: what can we learn from negative trials?
por: Jacobson, Sandra A, et al.
Publicado: (2011)

Olfactory Dysfunction and Its Association With Neuropathologic Proteins in Cerebrospinal Fluid From Patients With Parkinson Disease
por: Guo, Peng, et al.
Publicado: (2020)

Converging mediators from immune and trophic pathways to identify Parkinson disease dementia
por: Lue, Lih-Fen, et al.
Publicado: (2016)

Static and Dynamic Cognitive Reserve Proxy Measures: Interactions with Alzheimer’s Disease Neuropathology and Cognition
por: Malek-Ahmadi, Michael, et al.
Publicado: (2017)

Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body disease
por: Hall, Sara, et al.
Publicado: (2022)

Critical Appraisal of Amyloid Lowering Agents in AD
por: Decourt, Boris, et al.
Publicado: (2021)

Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology
por: Portelius, Erik, et al.
Publicado: (2018)

The Sun Health Research Institute Brain Donation Program: Description and Eexperience, 1987–2007
por: Beach, Thomas G., et al.
Publicado: (2008)

The neuropathological diagnosis of Alzheimer’s disease
por: DeTure, Michael A., et al.
Publicado: (2019)

PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with (18)F-AV-133 (florbenazine) in patients with Alzheimer’s disease and Lewy body disorders
por: Siderowf, Andrew, et al.
Publicado: (2014)

Deep learning from multiple experts improves identification of amyloid neuropathologies
por: Wong, Daniel R., et al.
Publicado: (2022)

Arteriolar neuropathology in cerebral microvascular disease
por: Fang, Chuo, et al.
Publicado: (2023)

The Neuropathologic Substrate of Parkinson Disease Dementia
por: Jellinger, Kurt A.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_459aecrkk2ajpepphkaot7auqs